Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of Rituximab in Rheumatoid Arthritis (Expanded Access)
NCT00502996Phase 3Completed
- Sponsor
- Roche
- Start
- Feb 2006
- Primary completion
- Dec 2008
- Modality
- Monoclonal Antibodies
- Countries
- 10
01
Overview
A Phase 3 trial of rituximab in rheumatoid arthritis (RA), sponsored by Roche. Started Feb 2006; status: completed.
02
Drugs
rituximab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT00502996.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00502996.